BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angiulli F, Conti E, Zoia CP, Da Re F, Appollonio I, Ferrarese C, Tremolizzo L. Blood-Based Biomarkers of Neuroinflammation in Alzheimer's Disease: A Central Role for Periphery? Diagnostics (Basel) 2021;11:1525. [PMID: 34573867 DOI: 10.3390/diagnostics11091525] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Alarcón-Enos J, Muñoz-Núñez E, Gutiérrez M, Quiroz-Carreño S, Pastene-Navarrete E, Céspedes Acuña C. Dyhidro-β-agarofurans natural and synthetic as acetylcholinesterase and COX inhibitors: interaction with the peripheral anionic site (AChE-PAS), and anti-inflammatory potentials. J Enzyme Inhib Med Chem 2022;37:1845-56. [PMID: 35815566 DOI: 10.1080/14756366.2022.2091554] [Reference Citation Analysis]
2 Yasuno F, Watanabe A, Kimura Y, Yamauchi Y, Ogata A, Ikenuma H, Abe J, Minami H, Nihashi T, Yokoi K, Hattori S, Shimoda N, Kasuga K, Ikeuchi T, Takeda A, Sakurai T, Ito K, Kato T. Estimation of blood-based biomarkers of glial activation related to neuroinflammation. Brain, Behavior, & Immunity - Health 2022. [DOI: 10.1016/j.bbih.2022.100549] [Reference Citation Analysis]
3 Pozzi FE, Conti E, Appollonio I, Ferrarese C, Tremolizzo L. Predictors of response to acetylcholinesterase inhibitors in dementia: A systematic review. Front Neurosci 2022;16:998224. [DOI: 10.3389/fnins.2022.998224] [Reference Citation Analysis]
4 Al-ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, Kaddoumi A. Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease. IJMS 2022;23:10572. [DOI: 10.3390/ijms231810572] [Reference Citation Analysis]
5 Rivas-arancibia S, Hernández-orozco E, Rodríguez-martínez E, Valdés-fuentes M, Cornejo-trejo V, Pérez-pacheco N, Dorado-martínez C, Zequeida-carmona D, Espinosa-caleti I. Ozone Pollution, Oxidative Stress, Regulatory T Cells and Antioxidants. Antioxidants 2022;11:1553. [DOI: 10.3390/antiox11081553] [Reference Citation Analysis]
6 Cucos CA, Milanesi E, Dobre M, Musat IA, Manda G, Cuadrado A. Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer's Disease, Common to APPV717I × TAUP301L Mice and Patients. Int J Mol Sci 2022;23:5799. [PMID: 35628609 DOI: 10.3390/ijms23105799] [Reference Citation Analysis]
7 Minochkin AK, Lobzin VY, Suchentseva NN, Popov OS, Apalko SV, Sherbak SG. New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. RJTAO 2022;14:35-42. [DOI: 10.14412/2074-2711-2022-2-35-42] [Reference Citation Analysis]
8 Pritam P, Deka R, Bhardwaj A, Srivastava R, Kumar D, Jha AK, Jha NK, Villa C, Jha SK. Antioxidants in Alzheimer's Disease: Current Therapeutic Significance and Future Prospects. Biology (Basel) 2022;11:212. [PMID: 35205079 DOI: 10.3390/biology11020212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
9 Schirò G, Balistreri CR. The close link between brain vascular pathological conditions and neurodegenerative diseases: Focus on some examples and potential treatments. Vascul Pharmacol 2021;142:106951. [PMID: 34942382 DOI: 10.1016/j.vph.2021.106951] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]